HiCM-188 therapy for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2026: Trial registered, NCT07496372

The trials

NCT07496372: A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)

State
Under way
Phase
Phase 3
People
80 planned
Started
30 Apr 2026
Primary completion
30 Jun 2027
Arms
Experimental group
Results
None posted
  1. 27 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.